PortfoliosLab logoPortfoliosLab logo
MCK vs. RMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MCK vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in McKesson Corporation (MCK) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MCK achieves a -1.56% return, which is significantly higher than RMD's -14.91% return. Over the past 10 years, MCK has outperformed RMD with an annualized return of 16.10%, while RMD has yielded a comparatively lower 13.55% annualized return.


MCK

1D
1.66%
1M
2.79%
6M
-1.05%
YTD
-1.56%
1Y
14.04%
3Y*
25.46%
5Y*
34.36%
10Y*
16.10%

RMD

1D
-2.20%
1M
4.67%
6M
-18.82%
YTD
-14.91%
1Y
-19.08%
3Y*
-1.09%
5Y*
-2.97%
10Y*
13.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MCK vs. RMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MCK
McKesson Corporation
-1.56%44.54%23.67%24.13%51.82%44.23%27.06%26.72%-28.40%11.95%
RMD
ResMed Inc.
-14.91%6.26%34.18%-16.55%-19.47%23.41%38.33%37.85%36.38%39.06%

Correlation

The correlation between MCK and RMD is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Jun 2, 1995

0.23

The correlation between MCK and RMD shifts across timeframes, from 0.15 (3 years) to 0.25 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MCK:

$94.36B

RMD:

$29.57B

EPS

MCK:

$38.53

RMD:

$15.50

PE Ratio

MCK:

20.92

RMD:

13.15

PEG Ratio

MCK:

0.28

RMD:

0.41

PS Ratio

MCK:

0.25

RMD:

3.61

Total Revenue (TTM)

MCK:

$403.43B

RMD:

$5.54B

Gross Profit (TTM)

MCK:

$14.55B

RMD:

$3.42B

EBITDA (TTM)

MCK:

$6.91B

RMD:

$2.10B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MCK vs. RMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MCK
MCK Risk / Return Rank: 5858
Overall Rank
MCK Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
MCK Sortino Ratio Rank: 5757
Sortino Ratio Rank
MCK Omega Ratio Rank: 5757
Omega Ratio Rank
MCK Calmar Ratio Rank: 5757
Calmar Ratio Rank
MCK Martin Ratio Rank: 5858
Martin Ratio Rank

RMD
RMD Risk / Return Rank: 1717
Overall Rank
RMD Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 1414
Sortino Ratio Rank
RMD Omega Ratio Rank: 1515
Omega Ratio Rank
RMD Calmar Ratio Rank: 2626
Calmar Ratio Rank
RMD Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MCK vs. RMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for McKesson Corporation (MCK) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MCKRMDDifference
Sharpe ratioReturn per unit of total volatility

+1.22

Sortino ratioReturn per unit of downside risk

+1.85

Omega ratioGain probability vs. loss probability

1.12

0.89

+0.23

Calmar ratioReturn relative to maximum drawdown

0.49

-0.54

+1.03

Martin ratioReturn relative to average drawdown

1.13

-1.09

+2.22

MCK vs. RMD - Sharpe Ratio Comparison

The current MCK Sharpe Ratio is 0.45, which is higher than the RMD Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of MCK and RMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MCK vs. RMD - Drawdown Comparison

The maximum MCK drawdown since its inception was -82.84%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for MCK and RMD.


Loading charts...

Drawdown Indicators


MCKRMDDifference

Max Drawdown

Largest peak-to-trough decline

-82.84%

-61.61%

-21.23%

Max Drawdown (1Y)

Largest decline over 1 year

-27.17%

-37.28%

+10.11%

Max Drawdown (3Y)

Largest decline over 3 years

-27.17%

-40.09%

+12.92%

Max Drawdown (5Y)

Largest decline over 5 years

-27.17%

-53.99%

+26.82%

Max Drawdown (10Y)

Largest decline over 10 years

-44.23%

-53.99%

+9.76%

Current Drawdown

Current decline from peak

-18.97%

-30.06%

+11.09%

Average Drawdown

Average peak-to-trough decline

-28.63%

-16.03%

-12.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.78%

18.53%

-6.75%

Volatility

MCK vs. RMD - Volatility Comparison

The current volatility for McKesson Corporation (MCK) is 8.00%, while ResMed Inc. (RMD) has a volatility of 11.80%. This indicates that MCK experiences smaller price fluctuations and is considered to be less risky than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MCKRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.00%

11.80%

-3.80%

Volatility (6M)

Calculated over the trailing 6-month period

23.87%

22.07%

+1.80%

Volatility (1Y)

Calculated over the trailing 1-year period

29.66%

26.47%

+3.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.35%

31.31%

-6.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.83%

31.62%

-2.79%

Dividends

MCK vs. RMD - Dividend Comparison

MCK's dividend yield for the trailing twelve months is around 0.41%, less than RMD's 1.18% yield.


PositionTTM20252024202320222021202020192018201720162015
MCK
McKesson Corporation
0.41%0.37%0.47%0.50%0.54%0.72%0.95%1.16%1.32%0.80%0.80%0.53%
RMD
ResMed Inc.
1.18%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Financials

MCK vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between McKesson Corporation and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
96.30B
1.43B
(MCK) Total Revenue
(RMD) Total Revenue
Values in USD except per share items

MCK vs. RMD - Profitability Comparison

The chart below illustrates the profitability comparison between McKesson Corporation and ResMed Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
4.2%
62.3%
Portfolio components
MCK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, McKesson Corporation reported a gross profit of 4.04B and revenue of 96.30B. Therefore, the gross margin over that period was 4.2%.

RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.

MCK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, McKesson Corporation reported an operating income of 2.09B and revenue of 96.30B, resulting in an operating margin of 2.2%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.

MCK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, McKesson Corporation reported a net income of 1.68B and revenue of 96.30B, resulting in a net margin of 1.8%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.


Frequently Asked Questions


MCK and RMD have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RMD has higher volatility (11.80%) compared to MCK (8.00%). In terms of maximum drawdown, MCK dropped -82.84% vs RMD's -61.61%.

MCK currently has the higher Sharpe Ratio (0.45 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MCK and RMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer